Pulmonary Fibrosis - 50 Studies Found
| Completed |
: A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis : Idiopathic Pulmonary Fibrosis : 2025-08-03 : Specified dose on specified days |
| Completed |
: Atezolizumab for Idiopathic Pulmonary Fibrosis : Idiopathic Pulmonary Fibrosis : 2025-08-03 : Atezolizumab 1200 mg administered via intravenous infusion every 3 weeks |
| Completed |
: Safety and Efficacy of Venetoclax in Idiopathic Pulmonary Fibrosis : Idiopathic Pulmonary Fibrosis : 2025-08-03 : 100 mg daily by mouth for 3 weeks This drug inhibits a protein (Bcl-2) that protects cells from undergoing programmed cell death. |
| ACTIVE_NOT_RECRUITING |
: A Study in People With Pulmonary Fibrosis to Monitor Cough With a Wearable Device : Pulmonary Fibrosis : 2025-08-03 : A wearable cough monitoring device, the Strados Labs Remote Electronic Stethoscope Platform (RESP)?? sensor, with an accompanying mobile application ( |
| Completed |
: Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis : Idiopathic Pulmonary Fibrosis (IPF) : 2025-08-03 : Pharmaceutical formulation: CapsulesMode of Administration: Oral |
| Completed |
: To Evaluate the Efficacy, Safety, and Tolerability of BBT-877 in Patients With IPF : Idiopathic Pulmonary Fibrosis : 2025-08-03 : BBT-877 24 weeks + Follow-up 4 weeks |
| COMPLETED |
: Dose Reduction and Discontinuation With Anti-Fibrotic Medications : Idiopathic Pulmonary Fibrosis : 2025-08-03 : Pirfenidone |
| COMPLETED |
: Burden of Nintedanib Non-adherence Among Idiopathic Pulmonary Fibrosis (IPF) Patients : Idiopathic Pulmonary Fibrosis : 2025-08-03 : Nintedanib |
| Completed |
: A Study to Evaluate LTI-03 in Newly Diagnosed Idiopathic Pulmonary Fibrosis (IPF) Patients : Idiopathic Pulmonary Fibrosis : 2025-08-03 : Caveolin-1-Scaffolding-Protein-Derived Peptide |
| Completed |
: Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis : Idiopathic Pulmonary Fibrosis : 2025-08-03 : PLN-74809 |